BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26

• Business

  ArQule, Inc. to Report Third Quarter 2008 Financial Results on Monday, November 10, 2008

  November 3, 2008

   · 

  1 min read
• Drug Development

  Anadys Pharmaceuticals, Inc. Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers

  November 3, 2008

   · 

  8 min read
• Policy

  Genesis Pharmaceutical, Inc. Files Counter Claims

  November 3, 2008

   · 

  2 min read
• Drug Development

  BioMarin Pharmaceutical Inc. Announces Initiation of Clinical Assessment Program for Morquio A Syndrome

  November 3, 2008

   · 

  5 min read
• Drug Development

  Halozyme Therapeutics, Inc. Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients

  November 3, 2008

   · 

  5 min read
• Drug Development

  Cell Therapeutics, Inc. Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial

  November 3, 2008

   · 

  5 min read
• Drug Development

  Oncolytics Biotech Inc. Collaborators Present Positive Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting

  November 3, 2008

   · 

  4 min read
• Drug Development

  EntreMed, Inc. Antiangiogenic Role of 2ME2 Demonstrated in Rheumatoid Arthritis Models

  November 3, 2008

   · 

  5 min read
• Pharm Country

  Welch Allyn Recognized at 2008 HIDA MedSurg Conference and Expo

  November 3, 2008

   · 

  1 min read
• Drug Development

  Romark Laboratories, L.C. Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at AASLD 2008

  November 3, 2008

   · 

  4 min read